Stay updated on Nivolumab and Urelumab in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page shows a revision update from v3.6.2 to v3.6.3, indicating a minor update to the page version. This reflects a small change to the page’s metadata or formatting without altering the study details.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a new version of the page. This update does not modify the study details or visible content.SummaryDifference0.1%

- Check31 days agoChange DetectedEnrollment status updated to No longer looking for participants, affecting recruitment visibility. New user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study), along with an updated Intervention/Treatment heading and the Revision: v3.6.0 label to reflect the latest update.SummaryDifference0.4%

- Check38 days agoChange DetectedRevision label changed from v3.5.4 to v3.5.5, reflecting a software version update on the page.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.5.4 was applied to the page, replacing the previous v3.5.3; this is a metadata/version update and does not modify the study data or content.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page’s footer/site revision version has been updated from v3.5.2 to v3.5.3, reflecting a maintenance or release update rather than any study-specific information.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Urelumab in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.